poisoning risk Recalls

592 recalls tagged with “poisoning risk”.

Health & Personal Care
HIGH
FDA DRUG

Zydus Chlorpromazine Hydrochloride 200 mg Recall Expands Nationwide Over CGMP Deviations

The FDA confirms a nationwide recall of Zydus Lifesciences Chlorpromazine Hydrochloride tablets 200 mg (NDC 70710-1133-1) distributed by Zydus Pharmaceuticals USA. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above acceptable intake. Consumers and healthcare providers should stop using the product immediately and contact the distributor for guidance.

Chlorpromazine Hydrochloride
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Tablets Recalled for N-Nitroso Desmethyl Chlorpromazine Beyond FDA

Chlorpromazine Hydrochloride Tablets, 200 mg, 100-count bottle, manufactured by Zydus Lifesciences Ltd. and distributed by Northstar Rx LLC, are under recall nationwide in the United States. The CGMP deviation involves elevated levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop use and contact their healthcare provider.

Zydus Lifesciences
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Allura Xper FD20 BiOS Battery Recall Affects 5,067 Units Worldwide

Philips Medical Systems Nederland B.V. recalls 5,067 Allura Xper FD20 imaging systems worldwide. The BIOS battery may deplete faster than planned, causing the system to fail to start. The issue affects 1,626 US and 3,441 international units. Customers should stop using affected devices and follow manufacturer instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Allura Xper FD20/20 Recall 115 Units Over Startup-Battery Risk (2025)

Philips Medical Systems Nederland recall 115 Allura Xper FD20/20 imaging systems worldwide after reports that the BIOS battery may deplete prematurely. The startup process may halt with no user alert. Hospitals and providers should stop using affected units and await manufacturer instructions.

Philips Medical Systems Nederland
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems FD20 Biplane OR Table Recall for BIOS Battery Depletion (2025)

Philips Medical Systems Nederland B.V. recalls Allura Xper FD20 Biplane OR Table models 722020 and 722025. Four units are affected worldwide, including two in the United States. The BIOS battery may deplete faster than expected, halting the system startup with no user warning. The recall advises stop-use and coordination with healthcare providers for instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Food & Beverages
HIGH
FDA FOOD

New Spirit Naturals Ultra Whey Protein Powder Recalled for Undeclared Milk Allergen

New Spirit Naturals recalled 37 units of Ultra Whey Protein Powder sold directly through its online store after undeclared milk allergen was detected. The recall is currently active with a high-hazard designation. Consumers who have purchased the product should not consume it and should contact the company for refunds or replacements.

New Spirit Naturals
undeclared allergen
Read more
Health & Personal Care
HIGH
FDA DRUG

High-Risk Antibiotic Recall: Sulfamethoxazole and Trimethoprim 800/160 mg Double Strength Packets Re

A high-risk recall of sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets is active nationwide in the United States. The Harvard Drug Group and distribution partners have halted use of a lot due to a foreign-substance finding in packaging material. No tablets tested positive for micro-organisms. Consumers should stop using the product and consult their healthcare providers.

SULFAMETHOXAZOLE AND TRIMETHOPRIM
Presence of
Read more
Health & Personal Care
HIGH
FDA DEVICE

Canon Medical System SPOT Fluoro Digital Radiography System Recall Affects 8 Units in US (2025)

Canon Medical System, USA recalls 8 SPOT Fluoro digital radiography systems in the United States after a software defect could expose patients to unintended X-ray exposure. The issue occurs when the acquisition program changes and the default ROI causes the collimator and static image to partially cover the collimated area. Stop using the affected devices and follow manufacturer instructions for a

Canon Medical System
It has
Read more
Health & Personal Care
HIGH
FDA DEVICE

Northeast Scientific NES Reprocessed 0.9mm Turbo Elite Laser Atherectomy Catheter Recall 2025

Northeast Scientific recalled 795 NES Reprocessed 0.9mm RX Turbo Elite Laser Atherectomy Catheters nationwide. The device is not cleared for marketing in the United States. The recall cites breaches in sterile barrier packaging that could compromise sterility. Hospitals and providers should stop using the device immediately and follow manufacturer instructions.

Northeast Scientific
Potential for
Read more
Health & Personal Care
HIGH
FDA DRUG

Granules Pharmaceuticals Amphetamine Salts Recall Over Impurities Degradation Specifications (2025)

Granules Pharmaceuticals recalled 11,895 bottles of an extended-release amphetamine product due to failed impurities and degradation specifications. The recall is active nationwide in the United States. The FDA notice lists a high hazard level and urges stop-use and contact with the company or a healthcare provider.

Dextroamphetamine Saccharate
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH
FDA DRUG

Ascend Laboratories Recalls ARIPIPRAZOLE 10 mg Tablets Over Superpotent Drug Risks (2025)

Ascend Laboratories, LLC recalls 2,256 bottles of ARIPIPRAZOLE 10 mg tablets distributed nationwide after discovering the product to be superpotent. The recall involves ARIPIPRAZOLE tablets manufactured by Alken Laboratories Ltd. in India and distributed in the United States. The recall date is August 28, 2025, with consumer notification by letter and guidance to stop use.

ARIPIPRAZOLE
Superpotent drug
Read more
Health & Personal Care
HIGH
FDA DRUG

Granules Pharmaceuticals Recall: 11,928 Bottles of Dextroamphetamine Mixed Salts Suspended for Impur

Granules Pharmaceuticals recalled 11,928 bottles of an extended-release amphetamine product. The recall date is 2025-08-28 for Dextroamphetamine saccharate and related salts. The FDA lists the reason as failed impurities and degradation specifications. The recall remains active as of 2025-10-01. Health care providers and patients should stop use and contact the manufacturer for guidance.

Granules Pharmaceuticals
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH
FDA DRUG

Granules Pharmaceuticals Dextroamphetamine Mixed Salts ER Capsules Recall 11,909 Bottles (2025)

Granules Pharmaceuticals recalled 11,909 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules sold nationwide to pharmacies and health care providers. The recall stems from a failure to meet impurities and degradation specifications. Patients taking this prescription should stop using the product and

Granules Pharmaceuticals
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH
FDA DRUG

Granules Pharmaceuticals Recalls 3,384 Bottles of Dextroamphetamine ER Capsules for Impurity Issues

Granules Pharmaceuticals Inc. recalls 3,384 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, 100 capsules per bottle, NDC 70010-029-01, Lot GPC250158A, Exp 06-22-2027. The recall concerns failed impurities/degradation specifications. Healthcare providers and consumers should stop using the

Granules Pharmaceuticals
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH
FDA DRUG

Granules Pharmaceuticals Amphetamine Capsules Recalled for Impurities Degradation Standards (2025)

Granules Pharmaceuticals recalled 9,917 bottles of mixed-salts amphetamine extended-release capsules nationwide. The recall was issued August 28, 2025 and remains active. The FDA cited failed impurities/degradation specifications as the reason. Healthcare providers and consumers should stop using the product immediately and contact Granules Pharmaceuticals for guidance.

Granules Pharmaceuticals
Failed Impurities/Degradation
Read more
Previous
12345...30
Next

Tag Statistics

Total Recalls
592

Related Tags

chemical hazardchoking hazardelectrical hazardimmediate actionreturn for refundnhtsa regulatedfda regulatedadult producttoddler productkitchenbathroomstop use immediately